In Silico Pharmacology provides a forum for research articles conceiving the interface between computational and experimental work in pharmacology and toxicology. The journal addresses computational approaches in drug design and multi-scale analysis of bioactive substances from the cellular up to the behavioural level.
- Editor-in-Chief
-
- Boris Gutkin,
- Pramod Nair,
- Defang OUYANG,
- Chang-Guo Zhan
- Publishing model
- Hybrid. Open Choice – What is this?
- Speed
- Submission to first decision: 70 days
- Acceptance to publication: 13 days
- Usage
- Downloads: 13,105 (2018)
Articles
-
-
Synthesis and biological activity of 4-amino-3-chloro-1H-pyrrole-2,5-diones
-
Quantum chemical calculation and binding modes of H1R; a combined study of molecular docking and DFT for suggesting therapeutically potent H1R antagonist
-
Design of novel amyloid β aggregation inhibitors using QSAR, pharmacophore modeling, molecular docking and ADME prediction
-
Identification of potential drug targets and inhibitor of the pathogenic bacteria Shigella flexneri 2a through the subtractive genomic approach
Advertisement
About this journal
- Electronic ISSN
- 2193-9616
- Abstracted and indexed in
-
- BIOSIS
- EBSCO Academic Search
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- Google Scholar
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Meta
- Naver
- OCLC WorldCat Discovery Service
- ProQuest Advanced Technologies & Aerospace Database
- ProQuest Central
- ProQuest Computer Science
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Pharma Collection
- ProQuest SciTech Premium Collection
- ProQuest Technology Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- PubMedCentral
- Reaxys
- Copyright information
-
© Springer-Verlag GmbH Germany, part of Springer Nature
